Real-time intelligence for thermal ablation.

Making ablation visible and actionable.

HEPTA combines microwave energy delivery, patented in-depth temperature sensing and proprietary predictive software to monitor the evolving treatment zone.

THE CLINICAL PROBLEM

Ablation needs more than energy delivery.
It needs real-time feedback.

Physicians plan and deliver the treatment, but they have limited information about the ablation zone as it forms inside the patient.

HOW HEPTA WORKS
SENSE

Passive microwave radiometry measures the tissue temperature at depth, remotely from the probe, throughout the ablation.

SCROLL
CLINICAL PATHWAYS

One platform. Two access routes.

A common core - ablation, monitoring and intelligence - designed for percutaneous and bronchoscopic ablation.

HEPTA microwave ablation generator with thermal and radiometric sensing probes
OUR SYSTEM

HEPTA's platform delivers microwave energy while its patented radiometry sensing technology acquires the data that powers real-time prediction — whichever route is used to reach the tumor.

Percutaneous ablation

Target anatomy
LiverKidney

Image-guided ablation delivered through the skin, with the introducer integrated into the device.

Different access. Same HEPTA intelligence — one sensing, prediction and visualization core beneath both routes.

COMPANY

A multidisciplinary team advancing real-time ablation monitoring.

HEPTA Medical was founded to close the gap between what physicians plan during tumor ablation and what they can see as treatment unfolds. The team brings together expertise in thermal therapies, medical devices, sensing and predictive software around one goal: real-time confidence in the operating room.

Leadership Team
Portrait of Thomas Bancel

Thomas Bancel

Chief Executive Officer
  • PhD — ESPCI, École Polytechnique, Stanford
  • Background in thermal therapies and physiological signals
  • MedTech and digital health entrepreneur
  • Leads strategy, financing and partnerships at HEPTA
Portrait of Bill Dickhans

Bill Dickhans

VP R&D
  • Extensive experience at Medtronic / Covidien
  • Former Lung Therapy Lead
  • Device development and systems engineering
  • Leads design and development at HEPTA
Board of Directors

Gérard Hascoët

Chairman MD Start

Philippe Boucheron

Board Member Bpifrance

Robert Kwok

Board Member M&L Healthcare

Pauline de Breteuil

Board Member UI Investissement

Jerome Edwards

Board Member Independent
Scientific Advisory Board
Portrait of Pr Lambros Tselikas

Pr Lambros Tselikas

Interventional Radiology Gustave Roussy
Portrait of Pr Benjamin Bondue

Pr Benjamin Bondue

Interventional Pulmonology Hôpital Erasme
Portrait of Dr Agathe Seguin

Dr Agathe Seguin

Thoracic Surgery Groupe Hospitalier Privé Ambroise Paré–Hartmann
Portrait of Dr Amir Hanna

Dr Amir Hanna

Interventional Pulmonology Hôpital Marie-Lannelongue
BACKED BY

Supported by investors and innovation partners.

MD Start
Supernova Invest
UI Investissement
M&L Healthcare
Bpifrance

In the press.

mind Health April 2026

Hepta Medical clôture sa série A à hauteur de 10 M€

Read article ↗
Les Échos March 2026

Cancer : Hepta Medical passe à la vitesse clinique

Read article ↗
Les Échos September 2024

Cancer du poumon : Hepta Medical invente l'ablation thermique

Read article ↗
CONTACT

Let's shape the next era of tumor ablation.

Connect with HEPTA to explore clinical, strategic and investment opportunities.

Contact us →

HEPTA Medical — Chez DocCity
5–11 rue Gardenat Lapostol, 92150 Suresnes, France
contact@heptamed.com